Listed health and beauty products manufacturer Star Combo Pharma has announced that it will increase capacity at its nutraceutical manufacturing site in Smithfield, in Sydney’s southwest, through an $11 million investment including in 13 new production lines.
According to Star Combo CEO Su Zhang, the $11 million investment is aligned with a strategy to lead contract manufacturing of premium vitamins and dietary supplements, and its commitment to keeping manufacturing in Australia. Zhang said a return on investment was expected within three years.
“Our competitive position will be significantly strengthened with this transformational investment and I’m excited with the future prospects for the company,” she said.
“I also look forward to working closely with our new investor (Goldenmax International Technology Limited) to leverage both their process manufacturing knowledge and extensive sales and distribution network as we commission the new production lines.”
Picture: Star Combo Pharma
Subscribe to our free @AuManufacturing newsletter here.